peptide elongation factor 2 has been researched along with Alzheimer Disease in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 4 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ma, T | 1 |
Cox, AO; Furdui, CM; Holland, CE; Kasica, NP; Koscielniak, E; Lee, J; Ma, T; Ryazanov, AG; Wang, X; Wu, H; Yang, Q; Yang, W; Zhou, X; Zimmermann, HR | 1 |
Lizarazo, S; Tsai, NP; Yook, Y | 1 |
Ma, T; Ryazanov, AG; Yang, W; Zhou, X | 1 |
Beckelman, BC; Kasica, NP; Keene, CD; Ma, T; Ryazanov, AG; Yang, W; Zhou, X; Zimmermann, HR | 1 |
Chen, Y; Klann, E; Ma, T; Marambaud, P; Vingtdeux, V; Viollet, B; Zhao, H | 1 |
Alafuzoff, I; Li, X; Pei, JJ; Soininen, H; Winblad, B | 1 |
Bierer, L; Gotlib, J; Haroutunian, V; Johnson, G; Merril, C; Nairn, AC; Wallace, W | 1 |
1 review(s) available for peptide elongation factor 2 and Alzheimer Disease
Article | Year |
---|---|
Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease.
Topics: Alzheimer Disease; Cognition; Elongation Factor 2 Kinase; Humans; Neuronal Plasticity; Peptide Elongation Factor 2; Phosphorylation; Signal Transduction | 2023 |
7 other study(ies) available for peptide elongation factor 2 and Alzheimer Disease
Article | Year |
---|---|
Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Elongation Factor 2 Kinase; Mice; Peptide Elongation Factor 2; Phosphorylation; Syndrome | 2022 |
Amyloid beta induces Fmr1-dependent translational suppression and hyposynchrony of neural activity via phosphorylation of eIF2α and eEF2.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Eukaryotic Initiation Factor-2; Fragile X Mental Retardation Protein; Humans; Mice; Peptide Elongation Factor 2; Phosphorylation | 2022 |
Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Hippocampus; Imidazoles; Long-Term Potentiation; Mice, Transgenic; Neuronal Plasticity; Peptide Elongation Factor 2; Phosphorylation; Protein Biosynthesis; Receptor, Metabotropic Glutamate 5 | 2021 |
Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice.
Topics: Alzheimer Disease; Animals; Dendritic Spines; Disease Models, Animal; Elongation Factor 2 Kinase; Female; Humans; Long-Term Potentiation; Male; Mice; Mice, Knockout; Peptide Elongation Factor 2; Phosphorylation; Post-Synaptic Density; Signal Transduction | 2019 |
Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; AMP-Activated Protein Kinases; Amyloid beta-Protein Precursor; Animals; Cells, Cultured; Elongation Factor 2 Kinase; Excitatory Postsynaptic Potentials; Female; Hippocampus; Humans; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Mice; Mice, Inbred C57BL; Peptide Elongation Factor 2; Presenilin-1; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Signal Transduction | 2014 |
Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain.
Topics: Adaptor Proteins, Signal Transducing; Aged; Aged, 80 and over; Alzheimer Disease; Autoantibodies; Brain; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Case-Control Studies; Cell Cycle Proteins; Elongation Factor 2 Kinase; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Male; Middle Aged; Peptide Elongation Factor 2; Phosphoproteins; Phosphorylation; Protein Kinases; TOR Serine-Threonine Kinases | 2005 |
Increased phosphorylation of elongation factor 2 in Alzheimer's disease.
Topics: Adenosine Diphosphate Ribose; Alzheimer Disease; Blotting, Western; Electrophoresis, Gel, Two-Dimensional; Humans; Nerve Tissue Proteins; Peptide Elongation Factor 2; Peptide Elongation Factors; Phosphoproteins; Phosphorylation; Polyribosomes; Protein Biosynthesis; Reticulocytes | 1992 |